DrugPatentWatch Database Preview
Drugs in Development Information for Lersivirine
» See Plans and Pricing
What is the drug development status for Lersivirine?
Lersivirine is an investigational drug.
There have been 9 clinical trials for Lersivirine.
The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2009.
The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Pfizer, ViiV Healthcare, and [disabled in preview].
Summary for Lersivirine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 22 |
| WIPO Patent Applications | 164 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2009-07-01) |
| Vendors | 40 |
Recent Clinical Trials for Lersivirine
| Title | Sponsor | Phase |
|---|---|---|
| Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects | ViiV Healthcare | Phase 1 |
| Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects | Pfizer | Phase 1 |
| A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022 | ViiV Healthcare | Phase 2 |
Clinical Trial Summary for Lersivirine
Top disease conditions for Lersivirine
Top clinical trial sponsors for Lersivirine
US Patents for Lersivirine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
